Multiple Choice
Why would a slow-release depot formulation be preferred when treating schizophrenia?
A) Eliminates the side effects associated with schizophrenia
B) Does not interfere with the metabolism of other drugs
C) Allows for once-a-day dosing because of its slow-release formulation
D) To allow for infrequent administration of the medication for maintenance therapy
Correct Answer:
Verified
Correct Answer:
Verified
Q1: Antagonizing which receptors is useful in the
Q2: Persons diagnosed with schizophrenia often see visions
Q4: What neurotransmitter is not associated with schizophrenia?<br>A)Acetylcholine<br>B)Glutamate<br>C)Cholecystokinin<br>D)Serotonin
Q5: MATCHING<br>Match the following generic drug names with
Q6: Traditional neuroleptics block DA at postsynaptic receptor
Q7: Which of the following is thought to
Q8: _ is the most significant neurotransmitter target
Q9: Not all neuroleptic agents bind to dopamine
Q10: MATCHING<br>Match the following generic drug names with
Q11: Neuroleptic malignant syndrome (NMS)is a life-threatening side